Thymosin Alpha 1

Accelerating

Thymosin Alpha 1 appears in 1,067 indexed publications going back to 1978, including 21 in the past twelve months. 31 registered trials appear on ClinicalTrials.gov.

1,067

Indexed publications

Past 12 months, against 13 the year before

Registered clinical trials

Monthly readers on Wikipedia, up 48%

Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
2015	29
2016	12
2017	12
2018	26
2019	12
2020	25
2021	16
2022	17
2023	30
2024	13
2025	16
2026	15

Public Attention

Who is looking it up

Monthly readers of the Thymosin Alpha 1 article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-122026-07

Clinical Trials

The registered pipeline

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase distribution across the most recently updated registered trials.

Not yet recruiting·Not applicable
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Nanjing Medical University · estimated completion 2027-12-31
Recruiting·Phase 1
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Tongji Hospital · estimated completion 2028-04-01
Recruiting·Phase 2
A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer
Sun Yat-sen University · estimated completion 2029-12-30
Active, not recruiting·Phase 2
The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC
Sun Yat-sen University · estimated completion 2026-08-30
Active, not recruiting·Phase 2
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
Beijing Friendship Hospital · completed 2024-12-01
Not yet recruiting·Not applicable
Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC
Xuanwu Hospital, Beijing · completed 2025-06-30

References

Most recent work

The newest indexed records mentioning Thymosin Alpha 1, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

2026-03-23·Virulence
Thymosin α1-induced secretion of the IL-15/RA complex by THP-1-derived dendritic cells restrains HIV latency <i>in vitro</i>
Chen C, Xun J, Wang J et al.
2026-05-29·Journal of gastroenterology and hepatology
Regarding IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8+ T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression
Sengul I, Sengul D. et al.
2026-06-01·Asian Pacific journal of cancer prevention : APJCP
Thymosin α1 Augments CD8⁺ T-Cell Activation and Reverses Exhaustion In Vitro
Mishra S, Telang G, Sureshbabu A et al.
2026-06-15·Cancer research
Thymosin Alpha-1 Restores Chemotherapy-Induced Antitumor Immunity by Chaperoning a MicroRNA Ligand of TLR7 in Dendritic Cells
Wei Y, Chen J, Zhang Y et al.
2026-03-26·Journal of gastroenterology and hepatology
IL-15 Plus Thymosin α1 Reduces Senescent Hepatic CD8<sup>+</sup> T Cells in Hepatocellular Carcinoma via PI3K/AKT Suppression
Wu F, Guo Z, Guan J et al.
2026-04-01·Integrative medicine (Encinitas, Calif.)
Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation
Mazza AD. et al.
2026-04-30·Radiation oncology (London, England)
Preliminary results from a phase II trial of spatially fractionated radiotherapy combined with immunotherapy and anti-angiogenic therapy in patients with bulky solid tumors: early evidence of promising efficacy and favorable safety
Zhou Y, Li Y, Zhu H et al.
2026-03-26·Immunopharmacology and immunotoxicology
Thymosin α1 improves the outcomes of patients with hepatitis B virus-related acute-on-chronic liver failure by restoring immune balance
Li ZH, Wu LL, Zhu YQ et al.

In the Catalogue

Thymosin Alpha 1 available from Polaris Research

Thymosin Alpha 1 10mg

Energy & Longevity

$1.99View product

Supplied as research materials for laboratory use. Free express delivery Australia wide.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-08-02.